Dale and Betty Bumpers Vaccine Research Center search   
Vaccines for Life
Office of the Director
Research Laboratories
Clinical Studies
Collaboration and Funding
Publications News Seminars Meetings Employment
Clinical Trials
About Clinical Trials Core
* Chief's Profile
* Program Areas
* Facts
* Meet the Staff
* FAQs
* Contact Us
* Virtual CTC Clinic Tour
VRC Clinical Trials
* Understanding Vaccine Clinical Trials
* Safeguards
* Vaccine Science
* Current VRC Clinical Trials
* Archive of VRC Clinical Trials
Update on HIV Vaccine
* IAVI Report: Ongoing Trials of Preventive HIV Vaccines (PDF) [Disclaimer]
* IAVI Report: AIDS Vaccine Trials 2006: Year in Review (PDF) [Disclaimer]
* Download presentation slides by Barney Graham, M.D., Ph.D.
AIDS Information
* HIV Statistics
* HIV Transmission
Join the Human Race against HIV/AIDS Join the Human Race against HIV/AIDS


Clinical Trials
About Clinical Trials Core

VRC Home


Chief, Viral Pathogenesis Laboratory and Clinical Trials Core

Picture of Barney GrahamDr. Barney Graham has been appointed Director of Clinical Studies and tenured investigator at the Dale and Betty Bumpers Vaccine Research Center (VRC). Dr. Graham comes to the VRC from Vanderbilt University School of Medicine, where he was professor of medicine and associate professor of microbiology and immunology. For the past 13 years, Dr. Graham also headed the AIDS Vaccine Evaluation Unit at Vanderbilt, part of the national clinical trials network funded by NIAID that tests candidate AIDS vaccines in humans.

Dr. Graham graduated magna cum laude from Rice University in Houston, and completed his M.D. at the University of Kansas School of Medicine, where he received the Roscoe Falls Morton Award for "outstanding senior student in internal medicine." He completed his internship and residency in internal medicine at Vanderbilt, where he also finished his Ph.D. before joining the university as a full-time faculty member. In 1993, Vanderbilt honored him with the Grant Liddle Research Appreciation Award for "promoting interest in research among young physicians."

NIH recognized the potential and importance of Dr. Graham's work early on, and has funded many of his studies on candidate vaccines for respiratory syncytial virus (RSV) and AIDS. In addition to his duties at Vanderbilt, Dr. Graham consults for many public health organizations, such as the World Health Organization, UNAIDS and the International AIDS Vaccine Initiative. He was recently appointed to the editorial board for the Journal of AIDS, and reviews manuscripts for major virology, immunology and clinical research journals. Dr. Graham has served on many NIAID committees and chaired the executive committee for the AIDS Vaccine Evaluation Group. He is a member of many professional scientific societies, including the American Society of Clinical Investigation, and is a Fellow in the American College of Physicians and the American Academy of Microbiology.

Dr. Graham's extensive experience in molecular virology and vaccine research, his pivotal role in establishing NIAID's AIDS Vaccine Evaluation Group, and his community involvement make him a unique selection for this position. As director of clinical studies, Dr. Graham oversees the design of clinical trials and selection of vaccine candidates, and will develop the infrastructure for the clinical trials program at the VRC. He also serves on the VRC Executive Committee, which analyzes the priorities of the Center and evaluates potential vaccine candidates. As a tenured investigator, Dr. Graham continues his laboratory studies in the pathogenesis of RSV and in the development of vaccines.

For more information on Dr. Graham's research program, please refer to his laboratory description or bibliography.

NIH Home

Department of Health and Human Services / National Institutes of Health / National Institute of Allergy and Infectious Diseases
Vaccine Research Center / 40 Convent Drive / Bethesda, Maryland 20892
E-mail the VRC / Directions and Maps / Site Map

Office of the Director | Research Laboratories | Clinical Studies | Collaboration and Funding
NIAID Website Privacy Statement | NIAID Website Accessibility Statement

Last updated: 06.07.06 (alt)

National Institute of Allergy and Infectious Disease Home